Phentermine, one of the earliest FDA-approved weight loss medications, functions by suppressing appetite.1 To determine whether patients who transitioned to phentermine after discontinuing a glucagon-like peptide-1 receptor agonist (GLP-1) medication maintained or experienced additional weight loss, we studied 7,773 patients who were prescribed phentermine following discontinuation of a GLP-1 medication. We categorized patients based on the amount of weight they lost while on GLP-1 treatment.
Patients who gained weight or maintained their weight while on a GLP-1 medication were most likely to experience weight loss after switching to phentermine with a median weight loss of around 3% in the year after discontinuing the GLP-1 medication. Patients who switched to phentermine after losing at least 20 pounds while on the GLP-1 medication were most likely to regain weight one year after discontinuing their GLP-1 medication, with more than half regaining some or all their weight.
We then evaluated whether patients prescribed phentermine after discontinuation of a GLP-1 medication were more likely to keep their weight off one year later compared to those who did not start phentermine after discontinuing their GLP-1. We found that 27.3% of patients who did not use phentermine after their GLP-1 medication regained all the weight they lost while on the GLP-1 compared to 19.3% of patients who started phentermine after discontinuing their GLP-1.